Total medical devices industry deals worth $17.1bn were announced globally for September 2021, with the $12.4bn acquisition of Hill-Rom Holdings being the sector’s biggest investment, according to GlobalData’s deals database.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked an increase of 10.7% over the previous month of $15.42bn and a rise of 39.8% when compared with the last 12-month average of $12.21bn.
In terms of number of deals, the sector saw a drop of 23.70% with 132 deals in September 2021 when compared to the last 12-month average of 173 deals.
In value terms, North America led the activity with deals worth $16.07bn in September 2021.
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDatamedical devices industry deals in September 2021: Top deals
The top five deals accounted for 88.02% of the overall value during September 2021.
The combined value of the top five deals stood at $15.02bn, against the overall value of $17.1bn recorded for the month.
The top five medical devices industry deals of September 2021 tracked by GlobalData were:
1) Baxter International $12.4bn acquisition deal with Hill-Rom Holdings
2) The $1.45bn acquisition of BK Medical Systems by GE Healthcare
3) Zoll Medical $538m acquisition deal with Itamar Medical
4) The $336m acquisition of 84% stake in DeVoro Medical by Boston Scientific
5) Mesa Laboratories $300m acquisition deal with Agena Bioscience
